Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2586 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | GRO-a | 7366.0 | 68 | |
| N2586 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | GRO-a | 7691.0 | 59 | |
| N2586 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | GRO-a | 3514.5 | 62 | |
| N2586 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 3 | GRO-a | 5462.0 | 59 | |
| RA2159 | Leptin | 1 | ng/mL | 3 | GRO-a | 4747.5 | 68 | ||||
| RA2159 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 3 | GRO-a | 2260.0 | 63 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | GRO-a | 2730.5 | 64 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | GRO-a | 4704.5 | 64 | |
| RA2159 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | GRO-a | 3601.5 | 42 | |
| RA2159 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 3 | GRO-a | 2409.0 | 59 | |
| N2586 | Leptin | 1 | ng/mL | 3 | GRO-a | 9108.0 | 54 | ||||
| N2586 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 3 | GRO-a | 7073.0 | 87 | |
| N2586 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | GRO-a | 6784.0 | 70 | |
| N2586 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | GRO-a | 6823.0 | 63 | |
| N2586 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | GRO-a | 3063.0 | 69 | |
| N2586 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 3 | GRO-a | 4578.0 | 50 | |
| RA2159 | Adiponectin | 5 | ng/mL | 3 | GRO-a | 3474.0 | 61 | ||||
| RA2159 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 3 | GRO-a | 1970.5 | 70 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | GRO-a | 3324.0 | 71 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | GRO-a | 3986.0 | 82 | |
| RA2159 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | GRO-a | 4171.5 | 62 | |
| RA2159 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 3 | GRO-a | 1999.0 | 62 | |
| N2586 | Adiponectin | 5 | ng/mL | 3 | GRO-a | 8740.0 | 69 | ||||
| N2586 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 3 | GRO-a | 6317.0 | 61 | |
| N2586 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | GRO-a | 5856.0 | 59 |